DrugDashboards

Enoxaparin Sodium

enoxaparin sodium · ENOXAPARIN SODIUM 300 mg/3mL · Injection · Intravenous; Subcutaneous · Fresenius Kabi USA, LLC

NDC 63323-0539-13 · 1 VIAL, MULTI-DOSE in 1 CARTON / 3 mL in 1 VIAL, MULTI-DOSE · NDA AUTHORIZED GENERIC · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.3% of the time — roughly 2× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.3%chance of a new FDA shortage posting for enoxaparin sodium (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $149.18 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA020164
TE code
—
Approval date
—
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of enoxaparin sodium (Injection)

LabelerStrengthFirst seenLast seen
Amphastar Pharmaceuticals, Inc.ENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesENOXAPARIN SODIUM 300 mg/3mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
Cardinal Health 107, LLCENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCENOXAPARIN SODIUM 300 mg/3mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ENOXAPARIN SODIUM 300 mg/3mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 3, 2026
NorthStar Rx LLCENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
Sandoz IncENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
Sandoz IncENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 3, 2026
Sanofi-Aventis U.S. LLCENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 3, 2026
Amphastar Pharmaceuticals, Inc.ENOXAPARIN SODIUM 300 mg/3mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 30 mg/.3mLJul 15, 2026Sep 2, 2026
BE Pharmaceuticals Inc.ENOXAPARIN SODIUM 60 mg/.6mLJul 15, 2026Sep 2, 2026
Civica, Inc.ENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedENOXAPARIN SODIUM 150 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedENOXAPARIN SODIUM 40 mg/.4mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedENOXAPARIN SODIUM 120 mg/.8mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedENOXAPARIN SODIUM 100 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedENOXAPARIN SODIUM 80 mg/.8mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Enoxaparin Sodium — NDC 63323-0539-13," retrieved September 3, 2026, https://drugdashboards.com/drug/63323053913.

Free to cite with attribution — see how the data is put together.